Researchers sought insight into the association between gout, a common condition among patients with chronic kidney disease, and the chances of being added to the kidney transplant wait list among patients receiving hemodialysis. They will present their findings at the National Kidney Foundation Spring Clinical Meetings 2025. The retrospective cohort study used data from the United States Renal Data System and included 150,176 adults aged 18 to 80 years who began hemodialysis between 2016 and 2019. Medicare was the primary payer for all participants, and gout status was identified via Medicare claim codes. ...
Nephrology Times
Nephrology Times delivers the latest news in kidney-related treatments and technologies with the goal of better informing care decisions and improving patient outcomes.
Advertisement
Latest News
Health professionals should promote the benefits of fruits and vegetables, especially to patients receiving dialysis.
Is metformin use ever appropriate for patients with advanced kidney disease and type 2 diabetes?
Oral iptacopan (Fabhalta) has become the first FDA-approved treatment for proteinuria in adults with C3 glomerulopathy.
A study compared stroke and dementia risk between race-free and previous eGFR equations.
Freely Filtered returns with another episode for NephMadness, this time, covering the hemodialysis region.
The Freely Filtered Filtrate discusses the top nephrology stories of 2024, including FLOW, cyberattacks, and IgAN trials.
Researchers estimated tuberculosis incidence and described the disease among the US population with kidney failure.
A study examined whether kidney function decline accelerated after COVID-19 versus other respiratory infections.
What were the effects of moving calcimimetics from the TDAPA to an increased bundled payment?
Babak Orandi spoke with us about a study showing that GLP-1 drugs have benefits for kidney transplant recipients with T2D.
Advertisement
Expert Interviews
In Print
World Congress of Nephrology 2025, rare kidney disease, renal nutrition, GLP-1 receptor agonists, and more.
ASN Kidney Week 2024, CKD risk with APOL1 variants in West African individuals, tribute to Dr. Barry Brenner, and more.
Conferences
The National Kidney Foundation's premier educational event designed for the interprofessional kidney health team
The annual scientific, educational, and networking meeting of the International Society of Nephrology
The American Society of Nephrology's annual meeting to highlight the latest scientific and medical advances in the field
ATC provides a forum for exchange of new scientific and clinical information relevant to transplantation.
Podcasts
Freely Filtered returns with another episode for NephMadness, this time, covering the hemodialysis region.
The Freely Filtered Filtrate discusses the top nephrology stories of 2024, including FLOW, cyberattacks, and IgAN trials.
Listen to the discussion of Chapter 17 of Dr. Burton Rose's book, focused on simple and mixed acid-base disorders.
Listen to part 2 of the discussion of Chapter 16 of Dr. Burton Rose's book, focused on edematous states.
Expert Columns
Ajay Singh discusses the state of rare kidney disease research.
Sarah Tolson highlights the concerns and challenges dialysis programs face under the 2025 ESRD PPS requirements.
Dr. Ajay Singh and others pay tribute to Dr. Barry Brenner, a leading nephrologist who passed away in August 2024.
Sarah Tolson shares what billing departments of dialysis programs need to know about the CMS final rule for the ESRD PPS.
It is important to understand the challenges Medicare Advantage plans present for ESRD care.
Dr. Ajay Singh discusses the reasons why medical students and residents are not choosing to pursue careers in nephrology.
Knowledge Hubs
Advertisement
Advertisement
Nephrology Times Chair
Ajay K. Singh, MBBS, FRCP, MBASenior Nephrologist, Brigham and Women’s Hospital | Senior Associate Dean, Harvard Medical School
Editorial Board
Mohamed G. Atta, MD, MPHProfessor of Medicine, Johns Hopkins School of Medicine
Timothy E. Bunchman, MDProfessor and Director, Pediatric Nephrology, Transplantation, and Rheumatology, Children’s Hospital of Richmond at VCU
Suphamai Bunnapradist, MD, MSProfessor of Medicine, David Geffen School of Medicine at UCLA | Research Director, Kidney Transplant Program, UCLA
Fernando C. Fervenza, MD, PhDProfessor of Medicine, Division of Nephrology and Hypertension, Mayo Clinic
Kenneth A. Liss, DOPartner, Hypertension and Nephrology Association, Eatontown, NJ
Joel M. Topf, MD, FACPAssistant Clinical Professor of Medicine, Oakland University William Beaumont School of Medicine
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.